000 01358 a2200373 4500
005 20250515090228.0
264 0 _c20071023
008 200710s 0 0 eng d
022 _a0065-2598
024 7 _a10.1007/978-0-387-71767-8_9
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBlom, Anna M
245 0 0 _aViral heparin-binding complement inhibitors--a recurring theme.
_h[electronic resource]
260 _bAdvances in experimental medicine and biology
_c2007
300 _a105-25 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAmino Acid Sequence
650 0 4 _aAnimals
650 0 4 _aComplement Activation
650 0 4 _aComplement Inactivating Agents
_ximmunology
650 0 4 _aHeparin
_xmetabolism
650 0 4 _aHumans
650 0 4 _aImmunity, Innate
_xphysiology
650 0 4 _aMolecular Sequence Data
650 0 4 _aProtein Structure, Secondary
650 0 4 _aProtein Structure, Tertiary
650 0 4 _aViral Envelope Proteins
_xgenetics
650 0 4 _aViral Proteins
_ximmunology
650 0 4 _aViruses
_ximmunology
700 1 _aMark, Linda
700 1 _aSpiller, O Brad
773 0 _tAdvances in experimental medicine and biology
_gvol. 598
_gp. 105-25
856 4 0 _uhttps://doi.org/10.1007/978-0-387-71767-8_9
_zAvailable from publisher's website
999 _c17415072
_d17415072